News Release

25 July 2011

Beximco Pharma introduces Veniron IV

Leading drug manufacturer Beximco Pharmaceuticals Ltd (BPL) has introduced new molecule Iron-sucrose, Veniron IV injection, for quicker & superior recovery from iron deficiency.

Veniron IV is preparation of Iron-sucrose 100 mg/5ml. Iron sucrose injection is a complex form of mineral iron. Iron is important for many functions in the body, especially for the transport of oxygen in the blood. Iron-sucrose injection is used to treat iron deficiencies and iron deficiency anemic patients with kidney disease. Iron sucrose injection may also be used in case of Postpartum anemia, Iron deficiency anemia and Preoperative anemia.

IV iron or Iron-sucrose injection is found more rapidly and effectively recovery from iron deficiency than oral iron supplement. As a result, Veniron improves Hb level very rapidly and effectively.